Literature DB >> 9570530

IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.

X Peng1, J E Remacle, A Kasran, D Huylebroeck, J L Ceuppens.   

Abstract

IL-12 is a heterodimeric cytokine produced by APC that promotes the development of CD4+ Th1 cells and their IFN-gamma production after TCR/CD3 triggering. We here investigated the capacity of IL-12 to modify the expression on T cells of CD40 ligand (CD40L or CD154), a molecule transiently expressed on activated T cells and known to be of utmost importance for cognate interaction with B cells and for activation of dendritic cells and macrophages. Our data demonstrate that IL-12 up-regulates CD40L expression on anti-CD3-activated human peripheral blood T cells. For optimal induction of CD40L, IL-12 synergizes with IL-2 as well as with other costimulatory interactions, such as B7/CD28. The effect of IL-12 was observed at both the protein and the mRNA level. T cells costimulated by IL-12 provided more efficient help for IL-4-dependent B cell proliferation and for IgG production than when activated in the absence of IL-12. This helper activity was blocked by an mAb against CD40L, indicating that the effect of IL-12 on B cells is mediated indirectly through CD40L. The data thus suggest that the effects of IL-12 on cellular and humoral immune responses are partly mediated through CD40L induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570530

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 2.  Targeting CD40L: a promising therapeutic approach.

Authors:  Dimitris Daoussis; Andrew P Andonopoulos; Stamatis-Nick C Liossis
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 3.  Dendritic cells in viral pathogenesis: protective or defective?

Authors:  Gabriele Pollara; Antonia Kwan; Philippa J Newton; Matthew E Handley; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

4.  Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway.

Authors:  J D Fayen
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

5.  Decrease of CD154 intensity on peripheral CD4+ T cells in autoimmune thyroid disease.

Authors:  M Watanabe; N Yamamoto; F Matsuzuka; A Miyauchi; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

6.  In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells.

Authors:  Stefano Vavassori; Yufang Shi; Chiann-Chyi Chen; Yacov Ron; Lori R Covey
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

Review 7.  Post-transcriptional regulation in lymphocytes: the case of CD154.

Authors:  Stefano Vavassori; Lori R Covey
Journal:  RNA Biol       Date:  2009-07-29       Impact factor: 4.652

8.  Differential regulation of Th1 responses and CD154 expression in human CD4+ T cells by IFN-alpha.

Authors:  H Shibuya; T Nagai; A Ishii; K Yamamoto; S Hirohata
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

9.  CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.

Authors:  Denise A Kaminski; Byung O Lee; Sheri M Eaton; Laura Haynes; Troy D Randall
Journal:  Immunology       Date:  2008-12-13       Impact factor: 7.397

10.  Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production.

Authors:  James T Snyder; Jijia Shen; Hooman Azmi; Jeannie Hou; Daniel H Fowler; Jack A Ragheb
Journal:  Blood       Date:  2007-03-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.